Skip to main content
. 2013 Jul-Sep;34(3):208–210. doi: 10.4103/0971-5851.123745

Table 1.

Response rates of chronic phase chronic myeloid leukemia to imatinib mesylate (n = 201)

graphic file with name IJMPO-34-208-g002.jpg